I today received a five page letter from Jeremy Hunt dealing with the eight points made. Unfortunately, I don't have a scanner but to give you an idea of the utter frustration and rage I am feeling at the moment, here is his reply to point 5 -Investigation into why NHS is paying exorbitant prices for T3 when the rest of Europe is not:
" The UK already has amongst the lowest prices for branded medicines in Europe and it's prices are referenced in many countries across Europe and beyond. This is shown in the most recent pharmaceutical price regulation scheme (PPRS) report to Parliament.
Under PPRS,, pharmaceutical companies may not increase the NHS list price of branded products before obtaining approval from the Department, other than an NHS list price change subsequent to the requirements on flexible pricing. Approval is based on a set of criteria under the terms of the scheme.
Within the flexible pricing provisions, companies may propose an initial price for a medicine that reflects it's value at the launch of the medicine, while retaining the freedom to increase or decrease this original price list as further evidence or new indications for the medicine emerge and change the effective value that the medicine offers to NHS patients."
The rest is in the same vein - all talk and no action !